- INDICATIONS AND USAGE DOSAGE AND ADMINISTRATION ADVERSE . . .
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RYTELO safely and effectively See full prescribing information for
- RYTELO® (imetelstat) HCP Website | RYTELOHCP
RYTELO® (imetelstat) is indicated for treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
- Rytelo: Package Insert Prescribing Information MOA
Rytelo package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
- DailyMed - RYTELO- imetelstat sodium injection, powder . . .
RYTELO for injection contains imetelstat, an oligonucleotide telomerase inhibitor for intravenous use Imetelstat sodium is a white to off-white or slightly yellow, amorphous, solid powder
- Imetelstat (RYTELO) National Drug Mini-Monograph July 2025
References RYTELO (imetelstat) for intravenous injection [prescribing information online] Foster City, CA: Geron Corporation 6 2024 Available at: rytelo_pi pdf Accessed 12 9 2024
- label - Food and Drug Administration
RYTELO (imetelstat) for injection is a sterile, preservative-free, white to off-white or slightly yellow lyophilized powder for intravenous infusion after reconstitution and dilution
- Rytelo | European Medicines Agency (EMA)
Rytelo is given by infusion (drip) into a vein, usually over a period of around two hours; it is given once every four weeks The recommended dose depends on the patient’s weight and can be adjusted in case of side effects At least 30 minutes before each infusion, patients should be given medicines to prevent or reduce potential side effects of the infusion A complete blood cell count and
- Rytelo (imetelstat) dosing, indications, interactions . . .
Medscape - Myelodysplastic syndrome dosing for Rytelo (imetelstat), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
|